TerminatedNot Applicable

Study of Attentional Disorders in Patients Suffering From Idiopathic Generalized Epilepsy.

Stopped: IP's decision

France33 participantsStarted 2022-04-26

Plain-language summary

Attentional disorders have been reported in neuropsychological studies evaluating patients suffering from generalized idiopathic epilepsy, but the data are disparate (in terms of test protocol). We aim to describe attentional and executive function disorder in IGE thanks to the Epitrack scale, validated in this specific population. Our secondary objective is to study the dynamic of cortical activity during an attentional task (the ANT), in order to describe the alteration of cortical networks in epileptic patients presenting with attentional disturbance.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Idiopathic generalized epilepsy followed-up during at least 2 years * At least one antiepileptic drug medication * No cognitive decline (MoCA score \>26) * Absence of concomitant pathology that could interfere with the purpose of the study. * Be affiliated to the social security system * Have signed an informed consent Exclusion Criteria: * Pregnancy * Not able to give consent (Article 1121-8 of the CSP) Vulnerable person Being deprived of liberty by judicial or administrative decision (Article L 1121-6 of the CSP) Have a high probability of not respecting the protocol or of abandoning the study

What they're measuring

Epitrack scale score

Timeframe: At 1 month after inclusion

Trial details

NCT IDNCT05530109

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-25

View on ClinicalTrials.gov More Idiopathic Generalized Epilepsy trials